Artelo enters glaucoma study agreement with Belfast Health Trust

Go back to Artelo enters glaucoma study agreement with Belfast Health Trust
ARISTOTLE (NASDAQ: ARTL) Delayed: 1.26 +0.03 (2.44%)
Previous Close $1.23    52 Week High $6.22 
Open $1.23    52 Week Low $2.74 
Day High $1.29    P/E N/A 
Day Low $1.21    EPS $-0.21 
Volume 251,487